SNN News and Press, Smith & Nephew SNATS Inc. From 07/27/22

OTCQX:AAUKF , ABEV , ABG , AGCO , OTCPK:AIQUF , ALGM , ALLE , ALNY , AMT , AOS , ARCH , ARES , ARGX , ASPS , ASX , OTCPK:ATGFF , ATNX , BAX , BC , BCS , BEN , BFH , BPOP , BT , BTU , BUD ...

Smith+Nephew to showcase latest innovations for sports medicine joint repair at 2022 AOSSM Annual Meeting PR Newswire LONDON , July 13, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces a robus...

Shares have not been this oversold for decades. 70%+ gross margin business along with strong return on capital metrics has us interested here. Valuation becoming very attractive. We may buy here on a convincing swing low. Intro If we look at a long-term chart of ...

Smith+Nephew ( NYSE: SNN ) said it launched an app called Wound Compass to help reduce practice variation in wound care. The British medical device maker said the clinical support app is a for health care professionals to help them in wound assessment and decision...

Smith+Nephew launches Clinical Support App to help reduce practice variation in wound care PR Newswire LONDON , July 12, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the WOUND C...

Smith+Nephew announces first robotic-assisted surgery using its LEGION™ CONCELOC™ Cementless Total Knee System PR Newswire LONDON , June 30, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company...

Argus Research has started Enovis Corp. (NYSE:ENOV) with a hold rating as it has concerns about EPS growth and "steep competition" from medical device peers. The firm does not have a price target. Analyst John Eade said that Enovis' record on EPS growth is not as strong as rivals, adding that...

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS PR Newswire LONDON , June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE...

Bioventus' diversified portfolio insulates the company from peers and enables it to innovate around its core offering. The company holds market-leading positions in several complex pain segments, offering non-invasive treatment solutions. There are high earnings and FCF growth pot...

Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION PR Newswire LONDON , June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology busine...